Additional studies with a larger sample of patients are needed to confirm the role of IL-6 in ovarian cancer diagnostics as well as further evaluate the clinical importance of IL-8 and TNF-α in patients with ovarian carcinoma and benign cystic lesions. This evidence concerns the gene CXCL8 and neoplasm.